Varicella zoster (VZV) vasculopathy: clinical features
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Varicella zoster (VZV) vasculopathy: clinical features. Immune compromise, HIV infection. Fully referenced neurology checklist.
Risk factors
- Immune compromise
- HIV infection
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis
- Steroid therapy
- Natalizumab
Possible pathogenetic mechanisms
Locked: subscribe to see this section.
Onset features
Locked: subscribe to see this section.
Vascular features
Locked: subscribe to see this section.
Non-vascular features
Locked: subscribe to see this section.
References
- Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009; 8:731-740.
- Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008; 70:853-860.
- Bakradze E, Kirchoff KF, Antoniello D, et al. Varicella zoster virus vasculitis and adult cerebrovascular disease. Neurohospitalist 2019; doi.org/10.1177/1941874419845732 (Epub ahead of print).
- Nagel MA, Jones D, Wyborny A. Varicella zoster virus vasculopathy: the expanding clinical spectrum and pathogenesis. J Neuroimmunol 2017; 308:112-117.
- Williams L, Delaney F, Kenny G, et al. Varicella-zoster vasculopathy causing carotid artery dissection. Neurol Clin Pract 2021; 11:e373-e375.
